Acute Kidney Injury in Adult Patients Supported by VA-ECMO
- Conditions
- Cardiogenic ShockAcute Kidney Injury
- Interventions
- Other: No intervention
- Registration Number
- NCT04082312
- Lead Sponsor
- Groupe Hospitalier Pitie-Salpetriere
- Brief Summary
Post-cardiotomy cardiogenic shock (PCCS) occurs in 2-6% of patients undergoing cardiac surgery, and 1% of cardiac surgery patients will require mechanical circulatory support using Veno-Arterial ExtraCorporeal Membrane Oxygenation (VA-ECMO). Acute Kidney Injury is a frequent complication in this population and negatively impacts the survival. We aimed to determine whether the timing of ECMO implantation influence the renal prognosis of these patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 347
- All patients admitted in post-operative of cardiac surgery
- Assisted by VA-ECMO
- Chronic hemodialysis
- Death occurring within the first 48 hours of VA-ECMO implantation
- Multiple VA-ECMO during the same hospitalization.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Group 3 No intervention Patients admitted in the surgical intensive care unit in post-operative of cardiac surgery between January 2013 and December 2016 + Assisted by VA-ECMO + died before D10 without KDIGO stage 3 AKI Group 1 No intervention Patients admitted in the surgical intensive care unit in post-operative of cardiac surgery between January 2013 and December 2016 + Assisted by VA-ECMO + with KDIGO stage 3 AKI Group 2 No intervention Patients admitted in the surgical intensive care unit in post-operative of cardiac surgery between January 2013 and December 2016 + Assisted by VA-ECMO + without KDIGO stage 3 AKI and alive at D10
- Primary Outcome Measures
Name Time Method Occurrence of a stage 3 AKI Day 10 after ECMO implantation Number of Participants with Stage 3 Acute Kidney Injury according to the Kidney Disease: Improving Global Outcomes (KDIGO) group
- Secondary Outcome Measures
Name Time Method Mortality at Day 30 Day 30 after ECMO implantation Number of Deceased Participants
Mortality at 6 months 6 months after ECMO implantation Number of Deceased Participants
Trial Locations
- Locations (1)
Dr Adrien Bouglé
🇫🇷Paris, France